Cancer, one of the
leading causes of death worldwide, remains a
challenge to treat. Over the last decades, targeted therapies have
emerged as a way to selectively target and treat the affected cells,
leaving the healthy ones intact. Nanomaterials, with their high surface
area, ease of functionalization, and interesting physicochemical properties,
are seen as promising carriers for therapeutic radionuclides. Their
optical, electronic, and magnetic properties can be supplemented by
the emitted ionizing radiation to form theranostic (therapeutic and
diagnostic) or combined therapeutic agents. This review describes
how different relevant therapeutic radionuclides can be incorporated
into inorganic nanoconstructs to be delivered to the cancer cells
and their impact on tumors. Different types of nanomaterials as well
as multiple ways of incorporating radionuclides and their impact on
the stability and both in vitro and in vivo performances are discussed.